NASDAQ · ONMD

OneMedNet Corp

Closing price · Nov 13, 2026 $5.34
Last insider buy price $5.54 Paid by Chief Medical Officer, Director, 10% owner Jeffrey Yu on Oct 9, 2026 (Form 4). Not today's price.

Latest quarter · ended Jun 30, 2026

Cash got weaker, but sales grew

descriptionFiled Aug 14, 2026
Revenue growthFaster
+88.4%
Quarter ended Sep 30, 2024: −56.4% sales vs. a year beforeQuarter ended Dec 31, 2024: −92.4% sales vs. a year beforeQuarter ended Mar 31, 2025: −44.8% sales vs. a year beforeQuarter ended Jun 30, 2025: −31.7% sales vs. a year beforeQuarter ended Sep 30, 2025: +24.6% sales vs. a year beforeQuarter ended Dec 31, 2025: +3326.9% sales vs. a year beforeQuarter ended Mar 31, 2026: −29.9% sales vs. a year beforeQuarter ended Jun 30, 2026: +88.4% sales vs. a year before
Sep '24Jun '26
$292K vs. $155K a year ago
Gross marginWorse
-193.5%
Quarter ended Sep 30, 2024: -59.2% gross marginQuarter ended Dec 31, 2024: -100.0% gross marginQuarter ended Mar 31, 2025: -163.5% gross marginQuarter ended Jun 30, 2025: -155.5% gross marginQuarter ended Sep 30, 2025: -125.4% gross marginQuarter ended Dec 31, 2025: 18.5% gross marginQuarter ended Mar 31, 2026: -395.8% gross marginQuarter ended Jun 30, 2026: -193.5% gross margin
Sep '24Jun '26
vs. -155.5% a year ago
Cash from operationsBetter
−$1.88M
Quarter ended Sep 30, 2024: −$1.9M cash from operationsQuarter ended Dec 31, 2024: −$2M cash from operationsQuarter ended Mar 31, 2025: −$1.85M cash from operationsQuarter ended Jun 30, 2025: −$2.19M cash from operationsQuarter ended Sep 30, 2025: −$1.75M cash from operationsQuarter ended Dec 31, 2025: −$1.71M cash from operationsQuarter ended Mar 31, 2026: −$1.54M cash from operationsQuarter ended Jun 30, 2026: −$1.88M cash from operations
Sep '24Jun '26
vs. −$2.19M a year ago
Share countDiluting
+28.6%
Quarter ended Sep 30, 2024: 28.18M sharesQuarter ended Dec 31, 2024: 30.76M sharesQuarter ended Mar 31, 2025: 30.57M sharesQuarter ended Jun 30, 2025: 46.1M sharesQuarter ended Sep 30, 2025: 51.01M sharesQuarter ended Dec 31, 2025: 52.2M sharesQuarter ended Mar 31, 2026: 54.43M sharesQuarter ended Jun 30, 2026: 59.29M shares
Sep '24Jun '26
59.29M shares vs. 46.1M a year ago

Numbers come from the company's own 10-Q and 10-K reports filed with the SEC. Each bar is one quarter, oldest on the left. The colored bar is the latest. Hover over or tap a bar to see its number.

Smart money pulse

What insiders and funds are doing

Mixed Insiders: as of Nov 13 Funds: as of Jun 30, 2026
−1000+100 0
  • info
    5 real insider sales in 12 months. $103K in total, not counting planned sales.

−100 means everyone selling, +100 everyone buying. This is data, not advice.

How the Pulse works

Pulse runs from −100 (everyone selling) to +100 (everyone buying). Half comes from insiders: real buyers vs. real sellers in the last 90 days (Form 4). Half comes from funds: funds that bought vs. funds that sold last quarter (13F). 13F is a snapshot of long positions on the last day of the quarter, filed up to 45 days later. It does not show short positions or trades since then.

Who owns it

22 funds report owning ONMD, same as the quarter before

Holdings as of Jun 30, 2026
New6
Added4
Held10
Trimmed2
Sold out6

Insider trades · last 12 months

Real buys and sales

● Open-market buy● Open-market sale
CEOCFOOther officersDirectorsDecJanFebMarAprMayJunJulAugSepOctNovStock grant · Jan 1 · 10,000 shStock grant · Apr 1 · $182KStock grant · Jul 6 · 35,000 shStock grant · Jul 6 · 65,000 shOpen-market buy · Feb 6 · $500KOpen-market buy · Apr 1 · $750KOpen-market buy · Apr 23 · $250KOpen-market buy · May 18 · $250KOpen-market buy · Jun 12 · $20.7KOpen-market buy · Jun 12 · $100KOpen-market buy · Jun 15 · $10.1KOpen-market buy · Jun 16 · $100KOpen-market buy · Jun 23 · $20.9KOpen-market buy · Jun 23 · $100KOpen-market buy · Jul 30 · $1000KOpen-market buy · Sep 10 · $90KOpen-market sale · Sep 14 · $16.5KOpen-market sale · Sep 15 · $18.9KOpen-market sale · Sep 21 · $19.9KOpen-market sale · Sep 22 · $37KOpen-market sale · Sep 24 · $10.8KOpen-market buy · Oct 7 · $750KOpen-market buy · Oct 9 · $250K
CEOCFOOther officersDirectorsJunJulAugSepOctNovStock grant · Jul 6 · 35,000 shStock grant · Jul 6 · 65,000 shOpen-market buy · Jun 12 · $20.7KOpen-market buy · Jun 12 · $100KOpen-market buy · Jun 15 · $10.1KOpen-market buy · Jun 16 · $100KOpen-market buy · Jun 23 · $20.9KOpen-market buy · Jun 23 · $100KOpen-market buy · Jul 30 · $1000KOpen-market buy · Sep 10 · $90KOpen-market sale · Sep 14 · $16.5KOpen-market sale · Sep 15 · $18.9KOpen-market sale · Sep 21 · $19.9KOpen-market sale · Sep 22 · $37KOpen-market sale · Sep 24 · $10.8KOpen-market buy · Oct 7 · $750KOpen-market buy · Oct 9 · $250K

Last 6 months. A wider screen shows 12.

Showing 19 real trades. Hidden: 4 stock grants. Those happen on a schedule and say little about what an insider thinks. Bigger dot means a bigger trade.

Real trades, newest first

Oct 9 Jeffrey Yu Past buys: 3 of 7 beat Chief Medical Officer, Director, 10% owner Open-market buy $250K 45,126 sh at $5.54
Oct 7 Thomas Kosasa Director, 10% owner Open-market buy $750K 129,758 sh at $5.78
Sep 24 Aaron Green CEO, Director Open-market sale $10.8K 1,667 sh at $6.48 Sold 1% of stake
Sep 22 Aaron Green CEO, Director Open-market sale $37K 5,000 sh at $7.39 Sold 2% of stake
Sep 21 Robert Golden CFO, Director Open-market sale $19.9K 3,000 sh at $6.63 Sold 3% of stake
Sep 15 Robert Golden CFO, Director Open-market sale $18.9K 3,000 sh at $6.30 Sold 3% of stake
Sep 14 Robert Golden CFO, Director Open-market sale $16.5K 2,500 sh at $6.60 Sold 3% of stake
Sep 10 Jeffrey Yu Past buys: 3 of 7 beat Chief Medical Officer, Director, 10% owner Open-market buy $90K 142,857 sh at $0.63
Jul 30 Thomas Kosasa Director, 10% owner Open-market buy $1000K 1,449,275 sh at $0.69
Jun 23 Jeffrey Yu Past buys: 3 of 7 beat Chief Medical Officer, Director, 10% owner Open-market buy $100K 158,730 sh at $0.63
Show 9 older real trades
Jun 23 Aaron Green CEO, Director Open-market buy $20.9K 36,650 sh at $0.57
Jun 16 Jeffrey Yu Past buys: 3 of 7 beat Chief Medical Officer, Director, 10% owner Open-market buy $100K 172,414 sh at $0.58
Jun 15 Aaron Green CEO, Director Open-market buy $10.1K 18,702 sh at $0.54
Jun 12 Thomas Kosasa Director, 10% owner Open-market buy $100K 158,730 sh at $0.63
Jun 12 Aaron Green CEO, Director Open-market buy $20.7K 36,920 sh at $0.56
May 18 Thomas Kosasa Director, 10% owner Open-market buy $250K 268,817 sh at $0.93
Apr 23 Thomas Kosasa Director, 10% owner Open-market buy $250K 280,898 sh at $0.89
Apr 1 Jeffrey Yu Past buys: 3 of 7 beat Chief Medical Officer, Director, 10% owner Open-market buy $750K 903,614 sh at $0.83
Feb 6 Thomas Kosasa Director, 10% owner Open-market buy $500K 595,238 sh at $0.84

"Past buys: 2 of 3 beat" means this insider bought stock in 3 earlier quarters, and in 2 of them what they bought did better than the typical stock over the next 6 months. A past record is data, not a forecast.

Showing every filing. Dashed circles are routine: grants, tax withholding, option exercises and planned sales.

Top holders

Biggest funds in ONMD

As of Jun 30, 2026
FundOwnsValueChange
Savant Capital, LLC12.2%$5.14MNew
Vanguard Capital Management LLC1.9%$819K+3%
Geode Capital Management, LLC0.6%$238K−1%
Vanguard Fiduciary Trust Co0.2%$97.9K+1%
BlackRock, Inc.0.2%$86K+73%

"Owns" is shares reported divided by shares outstanding.

Where this data comes from. Insider trades, fund holdings, activist stakes and company results come from public SEC EDGAR filings (Forms 4, 13F, 13D/13G, 10-Q and 8-K). Congress trades come from the STOCK Act reports members file with the House Clerk and the Senate. Daily closing prices come from post-no-preference/stocks on DoltHub, a community-run database shared under CC BY-SA 4.0; the prices we show stay under that license. They are each day's close, not live or official exchange prices.

This is data, not investment advice. About StockToast